Lupus Research Alliance Breaking Through Gala Raises Millions for Transformative Lupus Research
NEW YORK, NY. November 22, 2022 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala at Manhattan’s historic...
Kenneth M. Farber
A Message from LRA’s Kenneth Farber and Andrea O’Neill
May 1, 2022
Dear Margy,
The lupus community has always been strong, supportive, and ready for any and every challenge.
It’s that...
Lupus Research Alliance Breaking Through Gala Sets New Record, Raising $7.5 Million for Lupus Research
New York, NY. November 23, 2021 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala was the most successful...
LRA President Ken Farber Launches Lift Up Lupus for Awareness Month
May 1, 2021
Dear Friends,
2020 will forever be remembered as the year of COVID-19 with much sacrifice by all of us. Yet in many...
A Message From Ken Farber
Dear Friends,
I'm sure you agree—2020 was a year like no other.
Yet, despite the challenges presented by COVID-19, the Lupus...
Vaccines and Lupus: What to Know Amid COVID-19
January 14, 2021
LRA's President and CEO Kenneth Farber taped this video series - Vaccines and Lupus: What to Know...
Over Half of People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey
Updated January 4, 2021
New York, NY– December 16, 2020. More than half of people with lupus (54%) are willing...
LRA Hosts Star-Studded 2020 Virtual Fundraising Event with Selena Gomez and Lady Gaga
November 19, 2020
Lady Gaga and Selena Gomez Invite Global Lupus Community
New York, NY. November 19 – The Lupus Research Alliance...
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis
September 16, 2020
NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...
LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA
NEW YORK, NY. July 22, 2020. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA...
Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19
April 23, 2020
The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...
COVID-19 Update: A Message from LRA President & CEO
March 18, 2020
Dear Friends,
Your well-being is the utmost priority for all of us at the Lupus Research Alliance (LRA)....